BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22112781)

  • 1. Concomitant intensity modulated boost during whole breast hypofractionated radiotherapy--a feasibility and toxicity study.
    Teh AY; Walsh L; Purdie TG; Mosseri A; Xu W; Levin W; Koch CA; Fyles A; Liu FF; Cho BC
    Radiother Oncol; 2012 Jan; 102(1):89-95. PubMed ID: 22112781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated whole-breast radiation therapy: does breast size matter?
    Hannan R; Thompson RF; Chen Y; Bernstein K; Kabarriti R; Skinner W; Chen CC; Landau E; Miller E; Spierer M; Hong L; Kalnicki S
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):894-901. PubMed ID: 22543209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.
    Choi Y; Kim JK; Lee HS; Hur WJ; Chai GY; Kang KM
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):683-9. PubMed ID: 15927412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous-integrated boost intensity-modulated radiation therapy (SIB-IMRT) in the treatment of early-stage left-sided breast carcinoma.
    Singla R; King S; Albuquerque K; Creech S; Dogan N
    Med Dosim; 2006; 31(3):190-6. PubMed ID: 16905449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of concomitant tumour bed boost with whole breast irradiation in patients with locally advanced breast cancer undergoing breast-conserving therapy.
    Jalali R; Malde R; Bhutani R; Budrukkar A; Badwe R; Sarin R
    Breast; 2008 Feb; 17(1):64-70. PubMed ID: 17851077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dosimetric evaluation of intensity-modulated tangential beam versus conventional tangential irradiation for breast cancer].
    Huang XB; Jiang GL; Chen JY; Chen LF; Hu WG
    Ai Zheng; 2006 Jul; 25(7):855-60. PubMed ID: 16831277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.
    Krayenbuehl J; Oertel S; Davis JB; Ciernik IF
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1593-9. PubMed ID: 17931793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
    Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
    Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results.
    Lim TS; Cheung PC; Loblaw DA; Morton G; Sixel KE; Pang G; Basran P; Zhang L; Tirona R; Szumacher E; Danjoux C; Choo R; Thomas G
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):85-92. PubMed ID: 18355982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
    Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated boost to the dominant tumor region with intensity modulated stereotactic radiotherapy for prostate cancer: a sequential dose escalation pilot study.
    Miralbell R; Mollà M; Rouzaud M; Hidalgo A; Toscas JI; Lozano J; Sanz S; Ares C; Jorcano S; Linero D; Escudé L
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):50-7. PubMed ID: 19910135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients.
    Morganti AG; Cilla S; Valentini V; Digesu' C; Macchia G; Deodato F; Ferrandina G; Cece MG; Cirocco M; Garganese G; Di Lullo L; Traficante D; Scarabeo F; Panunzi S; De Gaetano A; Sallustio G; Cellini N; Sofo L; Piermattei A; Scambia G
    Radiother Oncol; 2009 Jan; 90(1):86-92. PubMed ID: 19010560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year results of whole breast intensity modulated radiation therapy for the treatment of early stage breast cancer: the Fox Chase Cancer Center experience.
    Keller LM; Sopka DM; Li T; Klayton T; Li J; Anderson PR; Bleicher RJ; Sigurdson ER; Freedman GM
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):881-7. PubMed ID: 22909414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-year outcomes of breast intensity-modulated radiation therapy with simultaneous integrated boost.
    McDonald MW; Godette KD; Whitaker DJ; Davis LW; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):523-30. PubMed ID: 19775834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is multibeam IMRT better than standard treatment for patients with left-sided breast cancer?
    Beckham WA; Popescu CC; Patenaude VV; Wai ES; Olivotto IA
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):918-24. PubMed ID: 17889273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost.
    Freedman GM; Anderson PR; Goldstein LJ; Ma CM; Li J; Swaby RF; Litwin S; Watkins-Bruner D; Sigurdson ER; Morrow M
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):347-53. PubMed ID: 17379430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study.
    Chan P; Yeo I; Perkins G; Fyles A; Milosevic M
    Radiat Oncol; 2006 May; 1():13. PubMed ID: 16722546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of radiation therapy for locally advanced adenoid cystic carcinomas with infiltration of the skull base using photon intensity-modulated radiation therapy (IMRT) and a carbon ion boost.
    Schulz-Ertner D; Didinger B; Nikoghosyan A; Jäkel O; Zuna I; Wannenmacher M; Debus J
    Strahlenther Onkol; 2003 May; 179(5):345-51. PubMed ID: 12740662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helical tomotherapy for locoregional irradiation including the internal mammary chain in left-sided breast cancer: dosimetric evaluation.
    Caudrelier JM; Morgan SC; Montgomery L; Lacelle M; Nyiri B; Macpherson M
    Radiother Oncol; 2009 Jan; 90(1):99-105. PubMed ID: 18977546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
    de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.